Effect of transcutaneous acupoint electrical stimulation on hemodynamics and prognosis of patients undergoing lung cancer surgery

Effect of transcutaneous acupoint electrical stimulation on hemodynamics and prognosis of patients undergoing lung cancer surgery under general anesthesia: a randomized controlled study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2100005215

Enrollment

Unknown

Registered

2021-10-04

Start date

2021-10-15

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamics and prognosis of patients undergoing lung cancer surgery

Interventions

Trial group:transcutaneous acupoint electrical stimulation

control group:none

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1) Patients undergoing lung cancer surgery 2) Age 18-64 years old 3) BMI index 18-30kg/?; 4) American Society of Anesthesiology (ASA) score I-II; 5) No radiotherapy or chemotherapy before surgery; 6) Patients who volunteered for the study;

Exclusion criteria

Exclusion criteria: 1) Communication barriers and unable to cooperate 2) People with a history of depression, anxiety, mental disorders and other psychological and psychiatric diseases 3) A history of chest surgery or a history of chronic pain; 4) Those who are confirmed/suspected to have a history of alcohol, analgesic or other drug abuse and addiction; 5) Those who are contraindicated for transcutaneous electrical stimulation, including those with local skin damage, infection, or implantation of electrophysiological devices in the body; 6) Patients with unstable angina, myocardial infarction and past arrhythmia within 3 months; 7) Preoperative visit blood pressure =180/110 mmHg (WHO-ISH Hypertension Guideline 3 hypertension); 8) Diabetic patients with diabetic complications and poor blood sugar control; 9) COPD GOLD grade III and IV, pulmonary fibrosis, uncontrolled asthma; 10) Use lung isolation methods other than DLT (such as difficult airway, tracheotomy, occluder, artificial pneumothorax); 11) Participated in other clinical trials within 3 months before being selected for the study; 12) The doctor in charge or the investigator believes that there are other situations that are not suitable for participating in this study (the reason needs to be recorded).

Design outcomes

Primary

Measure	Time frame
Catecholamine substance concentration;Blood gas analysis;Postoperative hospital stay;Hemodynamic index;Postoperative sleep score;Postoperative cognitive function score;Pain score;Postoperative ICU stay time;	—

Countries

China

Contacts

Public ContactChangjun Gao

gaocj74@163.com+86 13379227869

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026